Trial Profile
Pilot Study to Evaluate Subcutaneous Abatacept vs Placebo in RA Patients With Hepatitis B on Entecavir Background- a Pilot, Double-blind, Placebo-controlled, Randomized, Controlled Trial.
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase II
Latest Information Update: 03 Oct 2021
Price :
$35
*
At a glance
- Drugs Abatacept (Primary)
- Indications Rheumatoid arthritis
- Focus Adverse reactions; Pharmacodynamics
- 12 Nov 2020 Planned End Date changed from 1 Jun 2019 to 12 Jun 2018.
- 12 Nov 2020 Planned primary completion date changed from 30 Jun 2018 to 12 Jun 2018.
- 12 Nov 2020 Planned initiation date changed from 1 Mar 2014 to 1 Jul 2014.